PMI (Picard Medical) Total Debt per Share: $2.18 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PMI Picard Medical Inc PMI
4 GF Score
Price $3.64
! 4 Warning Signs
View Full Analysis

What is Picard Medical Total Debt per Share?

Picard Medical PMI +6.12% 4 Total Debt per Share is $2.18 as of Mar. 2026. GuruFocus rates PMI with a GF Score™ of 4/100. The stock has 4 warning signs investors should review.

$2.18 (As of Mar. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Picard Medical's Total Debt Per Share for the quarter that ended in Mar. 2026 was $2.18.

Picard Medical Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Picard Medical's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Picard Medical Total Debt per Share Chart

Picard Medical Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Debt per Share
1.36 6.53 14.52 4.73

Picard Medical Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.83 15.41 0.42 4.73 2.18
PMI
4GF Score
Picard Medical Inc PMI
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Picard Medical Total Debt per Share Calculation

Picard Medical's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.06+6.91)/1.47
=4.73

Picard Medical's Total Debt Per Share for the quarter that ended in Mar. 2026 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.01+3.27)/1.51
=2.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of $2.18 mean?
Picard Medical (PMI) has a Total Debt per Share of $2.18 as of Mar. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Picard Medical and its competitors.
Is Picard Medical's Total Debt per Share too high?
Picard Medical's current Total Debt per Share is $2.18. Overall, Picard Medical has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Picard Medical's Total Debt per Share compare to SINT and HSCS?
Picard Medical's Total Debt per Share of $2.18 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Medical Devices & Instruments company?
A good Total Debt per Share depends on the Medical Devices & Instruments industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Picard Medical and its competitors. Picard Medical's current Total Debt per Share is $2.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Picard Medical stock overvalued right now?
Picard Medical (PMI) has a current Total Debt per Share of $2.18. The current Total Debt per Share is $2.18. Picard Medical's overall GF Score™ is 4/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Picard Medical (PMI), the current Total Debt per Share is $2.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Picard Medical Business Description

Address 1992 East Silverlake, Tucson, AZ, USA, 85713
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.
4GF Score

Get the complete analysis for PMI

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.64
Price